In AD, proteostasis is unbalanced because of mutations and dysregulation of chaperones (miRNA-210 targets P4HB chaperone; Lee et al., 2015) and autophagy, leading to Aβ-amyloid peptides and phosphorylated Tau deposits. The gene discussed is MAPT; the disease is Alzheimer disease.